Market Tracker

01/30 6:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

183.24
Data as of Jan 30
 -4.81 / -2.56%
Today’s Change
136.37
Today|||52-Week Range
203.30
-0.97%
Year-to-Date

Today’s Trading

Previous close188.05
Today’s open186.81
Day’s range181.67 - 189.72
Volume2,144,043
Average volume (3 months)1,163,661
Market cap$36.3B
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+68.82%
Earnings growth (next 5 years)+20.38%
Revenue growth (last year)+34.85%
P/E ratio76.4
Price/Sales17.19
Price/Book15.15

Competitors

 Today’s
change
Today’s
% change
SHPGShire-2.91-1.31%
VRTXVertex Pharmaceutica...-4.00-3.50%
ZTSZoetis Inc-0.59-1.36%
PRGOPerrigo Company PLC-2.26-1.47%
Data as of 6:08pm ET, 01/30/2015

Financials

Last reporting dateJanuary 29, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, Treasurer &
Director
Leonard Bell
Chief Operating Officer &
Director
David L. Hallal
Corporate headquarters
Cheshire, Connecticut

Forecasts